Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Widodo Makmur Perkasa Tbk. (WMPP) Price & Performance

Indofarma Tbk.Trade
Widodo Makmur Perkasa Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Widodo Makmur Perkasa Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Widodo Makmur Perkasa Tbk. trades at Rp30 (market cap 853.15B, 31.14M 24h volume). The key difference: Widodo Makmur Perkasa Tbk. is far larger — about 2.2× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFWMPP
Market Cap
390.51B853.15B
Volume
31.14M
Lot
311.36K
Turnover
929.07M
Average Price
29.84
Value
929.07M
Indicative Equilibrium Price
30
Indicative Equilibrium Volume
130.05K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
WMPP
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Widodo Makmur Perkasa Tbk.

PT Widodo Makmur Perkasa Tbk (the Company) was established based on Notarial Deed No. 1 dated April 1, 2003 of Notary Durachman, S.H. The ultimate controlling shareholder of the Company is Mr. Tumiyana. The company commenced commercial operations in April 1, 2003

Read more on WMPP